421 related articles for article (PubMed ID: 15824348)
1. Reliability and validity of the CMT neuropathy score as a measure of disability.
Shy ME; Blake J; Krajewski K; Fuerst DR; Laura M; Hahn AF; Li J; Lewis RA; Reilly M
Neurology; 2005 Apr; 64(7):1209-14. PubMed ID: 15824348
[TBL] [Abstract][Full Text] [Related]
2. Neuropathy progression in Charcot-Marie-Tooth disease type 1A.
Shy ME; Chen L; Swan ER; Taube R; Krajewski KM; Herrmann D; Lewis RA; McDermott MP
Neurology; 2008 Jan; 70(5):378-83. PubMed ID: 18227419
[TBL] [Abstract][Full Text] [Related]
3. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
[TBL] [Abstract][Full Text] [Related]
4. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles.
Gallardo E; García A; Combarros O; Berciano J
Brain; 2006 Feb; 129(Pt 2):426-37. PubMed ID: 16317020
[TBL] [Abstract][Full Text] [Related]
5. [Molecular genetics of inherited neuropathies].
Takashima H
Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
[TBL] [Abstract][Full Text] [Related]
6. Utility of Charcot-Marie-Tooth Neuropathy Score in children with type 1A disease.
Haberlová J; Seeman P
Pediatr Neurol; 2010 Dec; 43(6):407-10. PubMed ID: 21093731
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus exacerbates motor and sensory impairment in CMT1A.
Sheth S; Francies K; Siskind CE; Feely SM; Lewis RA; Shy ME
J Peripher Nerv Syst; 2008 Dec; 13(4):299-304. PubMed ID: 19192070
[TBL] [Abstract][Full Text] [Related]
8. Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease.
Murphy SM; Herrmann DN; McDermott MP; Scherer SS; Shy ME; Reilly MM; Pareyson D
J Peripher Nerv Syst; 2011 Sep; 16(3):191-8. PubMed ID: 22003934
[TBL] [Abstract][Full Text] [Related]
9. The neurofilament light chain gene (NEFL) mutation Pro22Ser can be associated with mixed axonal and demyelinating neuropathy.
Bhagavati S; Maccabee PJ; Xu W
J Clin Neurosci; 2009 Jun; 16(6):830-1. PubMed ID: 19286384
[TBL] [Abstract][Full Text] [Related]
10. Disease course of Charcot-Marie-Tooth disease type 2: a 5-year follow-up study.
Teunissen LL; Notermans NC; Franssen H; Van Engelen BG; Baas F; Wokke JH
Arch Neurol; 2003 Jun; 60(6):823-8. PubMed ID: 12810486
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of the small heat shock protein 27 gene in chinese patients with Charcot-Marie-Tooth disease.
Tang B; Liu X; Zhao G; Luo W; Xia K; Pan Q; Cai F; Hu Z; Zhang C; Chen B; Zhang F; Shen L; Zhang R; Jiang H
Arch Neurol; 2005 Aug; 62(8):1201-7. PubMed ID: 16087758
[TBL] [Abstract][Full Text] [Related]
12. Late-onset HMSN 2: further evidence of genetic heterogeneity.
Dyck PJ
Neurology; 2008 Jul; 71(1):9-10. PubMed ID: 18591500
[No Abstract] [Full Text] [Related]
13. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations.
Azzedine H; Ravisé N; Verny C; Gabrëels-Festen A; Lammens M; Grid D; Vallat JM; Durosier G; Senderek J; Nouioua S; Hamadouche T; Bouhouche A; Guilbot A; Stendel C; Ruberg M; Brice A; Birouk N; Dubourg O; Tazir M; LeGuern E
Neurology; 2006 Aug; 67(4):602-6. PubMed ID: 16924012
[TBL] [Abstract][Full Text] [Related]
14. CMT1X phenotypes represent loss of GJB1 gene function.
Shy ME; Siskind C; Swan ER; Krajewski KM; Doherty T; Fuerst DR; Ainsworth PJ; Lewis RA; Scherer SS; Hahn AF
Neurology; 2007 Mar; 68(11):849-55. PubMed ID: 17353473
[TBL] [Abstract][Full Text] [Related]
15. Late-onset hereditary axonal neuropathies.
Bennett CL; Lawson VH; Brickell KL; Isaacs K; Seltzer W; Lipe HP; Weiss MD; Carter GT; Flanigan KM; Chance PF; Bird TD
Neurology; 2008 Jul; 71(1):14-20. PubMed ID: 18495953
[TBL] [Abstract][Full Text] [Related]
16. Electrodiagnosis of demyelinating neuropathies.
Van den Bergh PY; Jacquerye P; Piéret F
Acta Neurol Belg; 2000 Sep; 100(3):188-95. PubMed ID: 11098293
[TBL] [Abstract][Full Text] [Related]
17. The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.
Verhamme C; van Schaik IN; Koelman JH; de Haan RJ; de Visser M
Brain; 2009 Dec; 132(Pt 12):3252-62. PubMed ID: 19843647
[TBL] [Abstract][Full Text] [Related]
18. In vivo confocal microscopy of Meissner corpuscles as a novel sensory measure in CMT1A.
Almodovar JL; Ferguson M; McDermott MP; Lewis RA; Shy ME; Herrmann DN
J Peripher Nerv Syst; 2011 Sep; 16(3):169-74. PubMed ID: 22003930
[TBL] [Abstract][Full Text] [Related]
19. Correlation between weakness and axonal loss in patients with CMT1A.
Krajewski K; Turansky C; Lewis R; Garbern J; Hinderer S; Kamholz J; Shy ME
Ann N Y Acad Sci; 1999 Sep; 883():490-2. PubMed ID: 10586281
[TBL] [Abstract][Full Text] [Related]
20. Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy.
Sevilla T; Jaijo T; Nauffal D; Collado D; Chumillas MJ; Vilchez JJ; Muelas N; Bataller L; Domenech R; Espinós C; Palau F
Brain; 2008 Nov; 131(Pt 11):3051-61. PubMed ID: 18812441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
